Incyte Corporation is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals to obtain FDA approval.
“To obtain regulatory approval, we must first show that our drug products are safe and effective for target indications
through preclinical testing (animal testing) and clinical trials (human testing).” (Page S-11) Read the following article
Incyte Corp. is a biopharmaceutical company, which focuses on the discovery, development, development, formulation, manufacturing and commercialization of proprietary therapeutics to treat serious unmet medical needs, primarily in oncology. Its product, Jakafi, a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE. [Source: MarketWatch]
Company Website: https://www.incyte.com